Vir Biotechnology (VIR) Trades Higher in Sympathy with Janux Therapeutics (JANX)
Tweet
Share
E-mail
Get Alerts VIR Hot Sheet
Join SI Premium – FREE
Vir Biotechnology Inc. (NASDAQ: VIR) Trades Higher in Sympathy with Janux Therapeutics (NASDAQ: JANX)
- Janux Therapeutics Surges 40% After Encouraging Efficacy and Safety Profile Observed in Phase 1a Dose Escalation for JANX007 in mCRPC
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Google and Blackstone data-center venture hits delays at key sites - Bloomberg
- LIV Golf files Chapter 11 bankruptcy in New Jersey
- LIV Golf files for chapter 11, seeks player-majority ownership
Create E-mail Alert Related Categories
Corporate News, Momentum MoversRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
